A Phase 4 interventional study of DePuy P.F.C.® Sigma Rotating Platform Knee in Osteoarthritis, Knee, sponsored by Queen's University. Completed at 3 sites in Canada. Open to participants aged 45 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-09-27.
Sponsored by Queen's University · Phase 4, Interventional, and Treatment
Primary Research Questions:
3,391 studies on the registry are indexed under Osteoarthritis, Knee; 628 are open to participants now.
This study's enrollment of 91 is above the median of 69 across 2,808 interventional studies indexed under Osteoarthritis, Knee.
Browse Osteoarthritis, Knee studies →Queen's University is the lead sponsor of 207 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
DePuy P.F.C.® SigmaTM Posterior Cruciate Substituting Knee
Rotating Platform Knee
Device: DePuy P.F.C.® Sigma Rotating Platform Knee
no details
Also known as: no other name
Gait and radiographic parameters
Time frame: 0
Knee pain, function
Time frame: 0
The record gives a start of Oct 2006, a primary completion of Dec 2012 and a completion of Dec 2012. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.